Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-25

Clinical Trial Update: Impact of Escitalopram on Sperm DNA Fragmentation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating escitalopram's impact on sperm DNA fragmentation in men with infertility was terminated, and the study results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lexapro (escitalopram)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Sperm DNA Fragmentation, Infertility, Male | Phase 2 | Status: TERMINATED | Results posted: 2025-03-25